Epigenetics education: will a video boost public understanding?
NCT ID NCT07020234
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study surveyed over 2000 healthy adults from different racial and ethnic groups to see if watching an educational video about epigenetics improves their knowledge and acceptance of using this science in medicine. Participants watched either an epigenetics video or a nanotechnology video (for comparison) and then answered questions. The goal is to find better ways to explain how things like pollution and exercise can turn genes on or off.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors communicate better about how environment and lifestyle affect genes, potentially leading to more personalized health advice.
- What could go wrong
- This is a survey study, not a treatment trial. It measures opinions and knowledge, not health outcomes, so it won't directly change medical care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test